Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2664_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
43 Мб
Скачать
USMLE Step 2 CK
Note
Sclerosing cholangitis does not correlate to disease activity.
l Internal Medicine
INFLAMMATORY BOWEL DISEASE
Inflammatory bowel disease (IBD) is a term comprising 2 disease entities: Crohn’s disease (CD) and ulcerative colitis (UC). They can be discussed simultaneously because of the large
degree of overlap in terms of presentation, testing, and treatment.
• Both CD and UC are idiopathic disorders of the bowel associated with diarrhea, bleeding, weight loss, fever, and abdominal pain.
• Both are most accurately diagnosed with endoscopy and sometimes with barium stud­ies, “string sign” on small bowel follow through after barium meal in CD.
• Both are treated with anti-inflammatory medications, such as mesalamine, azathio­prine, and 6-mercaptopurine (6MP).
• Steroids are used for acute exacerbations of both diseases.
Clinical Presentation. IBD presents with fever, diarrhea, weight loss, and, occasionally, abdom­inal pain and bleeding. The extraintestinal manifestations of IBD are episcleritis, scleritis and iritis, sclerosing cholangitis, joint pains, and skin manifestations, such as pyoderma gangreno­sum or erythema nodosum.
Crohn’s disease is more likely to be associated with a palpable abdominal mass because CD has granulomas in the bowel wall that are transmural in nature. This can lead to the different loops of bowel being inflamed and sticking together, forming a mass. The abdominal masses of CD can be palpated and cause pain. CD is not necessarily continuous, and one hallmark of the disorder is that there are “skip lesions,” or areas of normal tissue in between the areas of disease.
UC is limited exclusively to the large bowel. It is exclusively a mucosal disease, and although it can cause bleeding, it does not result in fistula formation. UC has no skip lesions, no fistula formation, and no oral or perianal involvement. UC is more likely to cause bloody diarrhea.
Both forms of IBD can lead to colon cancer after 8–10 years of involvement of the colon. If the CD does not result in colonic involvement, then it will not lead to cancer. Complications of Crohn’s disease are calcium oxalate kidney stones, diarrhea, and cholesterol gallstones.
Diagnosis. IBD is diagnosed with endoscopy and sometimes with barium studies. (CD can result in deficiency of vitamin B12, calcium, vitamin K, and iron because of malabsorption.) Anti– Saccharomyces cerevisiae antibodies (ASCA) are associated with CD, and antineutrophil cytoplas­mic antibody (ANCA) is associated with UC. If a patient is ASCA positive and ANCA negative, he has a >90% chance of having CD. If the patient is ASCA negative and ANCA positive, he has a >90% chance of having UC.
Prothrombin time may be prolonged in CD because of vitamin K malabsorption. Kidney stones form more often in CD because the fat malabsorption results in a low calcium level and an increased absorption of oxalate, which forms kidney stones.
Treatment. Mesalamine derivatives are the mainstay of therapy for IBD in all of its forms. Pentasa is a form of mesalamine released in both the upper and lower bowel; hence, it is used in CD. Asacol is a form of mesalamine released in the large bowel, and it is most use­ful for UC. Rowasa is used exclusively for rectal disease. Sulfasalazine was used in the past for the same effect. The difficulty with sulfasalazine is that the high load of sulfa delivered causes a number of adverse effects, such as rash, hemolysis, and allergic interstitial nephri­tis. Sulfasalazine also causes reversible infertility in men and leukopenia by its sulfapyridine group.
90
Chapter 4
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Acute exacerbations of IBD are treated with high-dose steroids. Budesonide is a form of steroid that is ideal for IBD. It has a strong local effect when used orally, but is largely cleared by the liver in a first-pass effect. This limits the amount of systemic toxicity. Azathioprine and 6-mer­captopurine are associated with drug-induced pancreatitis, but are still used on a long-term basis to try to keep patients off steroids. Ciprofloxacin and metronidazole are used for CD in those with perianal disease. Infliximab is used for CD in those who form fistulae or have disease refractory to the other forms of therapy. There has been re-activation of tuberculosis with inflix­imab, and it is important to test for latent tuberculosis with a purified protein derivative (PPD) prior to treatment. If the PPD is positive, then patients should receive isoniazid. The most com­mon side effect of infliximab is arthralgias. Balsalazide and olsalazine are other forms of mesala­mine that are only active in the colon and are used occasionally.
Surgery is curative in UC; almost 60% of patients will require surgery within 5 years after diagno­sis due to refractory symptoms or severe disease. Surgery is not very effective in CD and disease tends to reoccur at the site of anastomosis.
l Gastroenterology
DIARRHEA
Diarrhea is increased frequency or volume of stool per day; stool can also be defined as diar­rhea if the number of stools per day is few, but their consistency is watery.
Pathogenesis. The most common causes of diarrhea are of an infectious, antibiotic-associat­ed, or lactose-intolerance etiology or from irritable bowel or carcinoid syndrome.
Clinical Presentation. The patient is often hypotensive, febrile, and experiencing abdominal pain.
Diagnosis. The first thing to do in the evaluation of diarrhea in terms of direct patient care is to see if there is hypovolemia as defined as hypotension or orthostasis. This is more important than determining the specific etiology because of the chance that the patient may die while waiting for the results to come back.
Treatment. No matter the etiology, if the patient is hypotensive, febrile, and having abdomi­nal pain, he or she should be admitted to the hospital and given IV fluids and antibiotics. The presence of blood in the stool is especially serious and is probably the single strongest indica­tion for the use of antibiotics, such as ciprofloxacin.
Infectious Diarrhea
For all patients, assume that new-onset diarrhea has an infectious etiology. After an infectious cause is excluded, then the other possible causes can be systematically ruled out.
In general, to exclude infection, stool should be evaluated for the presence of white cells or “fecal leukocytes,” as well as culture and ova and parasite examination. Clostridium difficile toxin and stool Giardia-antigen testing are done when there are clues to these diagnoses in the history.
Note
With management of diarrhea, determine when to admit the patient and when to use IV fluids and antibiotics. That is more important than determining the precise causative agent.
The most common causes of infectious diarrhea are Campylobacter and Salmonella, especially in patients with sickle cell and achlorhydria. One can only make a definitive determination of the etiology with a stool culture.
91
USMLE Step 2 CK
l Internal Medicine
Clinical presentation
Table 4-1. Clues to the Diagnosis of Infectious Diarrhea Prior to Results of Culture
Causative Agent Patient Symptoms or History Additional Comments
Bacillus cereus Ingestion of refried Chinese food and the
spores from Bacillus that it contains. Vomiting is prominent. Blood is never present.
Campylobacter Reactive arthritis, Guillain-Barré syndrome Most common cause of bacterial gastroenteritis
Cryptosporidia, Isospora
E. coli 0157:H7 Associated with the ingestion of contaminated
Giardia The ingestion of unfiltered water, as on a
Salmonella Ingestion of chicken and eggs, dairy products
Scombroid Patients who ingest contaminated fish
Found in HIV-positive patients with <100/mm3 CD4 cells
hamburger meat. The organism can release a Shiga toxin, provoking hemolytic uremic syndrome.
camping trip or in the mountains, or in drinking fresh lake water. Giardia never gives blood in the stool. There is abdominal fullness, bloating, and gas.
experience vomiting, diarrhea, flushing, and wheezing within minutes of eating it.
Short incubation period (1–6 hours)
Hemolytic uremic syndrome happens when the organism dies; that is why antibiotics are contraindicated. Platelet transfusions are also contraindicated, even if the platelet count is low because the new platelets may only make it worse.
Giardia can also simulate celiac disease in terms of causing fat and vitamin malabsorption if it is not eradicated.
Organisms invade, producing and then releasing histamine into the flesh of fish, such as tuna, mahi mahi, and mackerel.
Shigella, Yersinia No clues strong enough to point to the
etiology until the results of the stool culture are known.
Vibrio parahaemolyticus
Vibrio vulnificus Also in raw shellfish, but has a particularly
Viral Children in day-care centers; the absence of
Staphylococcus aureus Ingestion of dairy products, eggs, salads.
Ciguatera-toxin 2–6 hours after ingestion of large reef fish
Ingestion of raw shellfish, such as mussels, oysters, and clams
high incidence in people with underlying liver disease or disorders of iron metabolism. Also associated with the development of skin bullae.
blood and white cells
Upper GI symptoms (nausea/vomiting) predominate; rarely diarrhea.
(grouper, red snapper, and barracuda). Also neurological symptoms paresthesia, weakness, and reversal of heat and cold.
Yersinia can mimic appendicitis. Also common in people with iron overload, e.g., hemochromatosis.
Typically presents as severe systemic gastroenteritis in patients with underlying disease (esp. chronic liver disease)
Typically presents as severe systemic gastroenteritis in patients with underlying disease (esp. chronic liver disease)
No systemic manifestation
Short incubation period (1–6 hours)
92
Chapter 4
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Diagnosis. Stool for fecal leukocytes is the most useful test that can be done immediately. Fecal leukocytes are only found when there has been invasion of the intestinal mucosa, as in dysentery, which is a bacterial infection of the bowel, producing diarrhea and bloody stool.
Invasive organisms need 24 to 36 hours to produce their effect and never give blood in the stool within the first few hours of their ingestion. (The only exception is the protozoan Entamoeba histolytica, which can give blood or white cells in stools.) The invasive organisms are Salmonella, Shigella, Campylobacter, Vibrio parahaemolyticus, Yersinia, Escherichia coli, and Vibrio vulnificus (think people drinking sea water). The most definitive test for these bacterial organisms is a stool culture.
Cryptosporidiosis is diagnosed with a unique test, a modified acid-fast test. The routine ova and parasite examination does not reliably detect cryptosporidiosis.
Giardia is best diagnosed with an ELISA stool antigen test. A single stool antigen test has 90% sensitivity. Three stool ova and parasite examinations have only 80% sensitivity.
l Gastroenterology
Treatment. Most cases of food poisoning and infectious diarrhea will resolve spontaneously and will not need specific antimicrobial therapy. Even when they cause severe disease, as defined by high-volume stools with dehydration, antibiotics generally do not help. Antibiotics are used if there is abdominal pain, blood in the stool, and fever. The decision to use antibiot­ics is always made prior to knowing the result of the stool culture, so the treatment is always empiric and then modified when the culture results are known. The best empiric therapy for infectious diarrhea is ciprofloxacin or the other fluoroquinolones ± metronidazole.
Scombroid poisoning is treated with antihistamines, such as diphenhydramine. Giardia is still treated primarily with metronidazole. A newer agent for Giardia is tinidazole, which is effec­tive in a single dose. Cryptosporidiosis is treated with nitazoxanide, although it has limited efficacy. The truly effective therapy for cryptosporidiosis is to raise the CD4 count to >100/ mm3 with antiretrovirals. Nitazoxanide is superior to paromomycin for cryptosporidium.
There is no specific therapy for viral diarrhea. Patients are managed with fluid and electrolyte support until the infection resolves.
Antibiotic-Associated and C. difficile-Associated Diarrhea
The term antibiotic-associated diarrhea (AAD) refers usually to a benign, self-limited diarrhea following the use of antimicrobials. Typically, no pathogens are identified and the diarrhea is caused by changes in the composition and function of the intestinal flora as well as increased motility (as occurs with agents like erythromycin). Most patients respond to supportive mea­sures and discontinuation of antibiotics.
Note
• TMP/SMX for Isopora
• Doxycycline for Vibrio
vulnificus
Rifaximin for travelers’
diarrhea
Note
Prophylactic antibiotics for traveler’s diarrhea is never a correct approach.
On the other hand, Clostridium difficile diarrhea (C. diff) refers to a spectrum of diarrheal ill­nesses caused by the toxins produced by this organism, including severe colitis with or without the presence of pseudomembranes. For exam purposes, this discussion will focus on C. diff.
Pathogenesis. Any antibiotic can lead to diarrhea with C. diff, although antibiotics that are broad spectrum are more likely to do so. Clindamycin may have one of the highest frequencies of association, as do fluoroquinolones and cephalosporins.
C. diff diarrhea is largely a nosocomial disease and is the most frequent cause of diarrhea in hospitalized patients. Its occurrence in the outpatient setting, other than in patients confined to nursing homes, is much less common. Recent meta-analysis suggests a significant associa­tion between C. difficile and the use of proton pump inhibitors.
93
USMLE Step 2 CK
l Internal Medicine
• Epidemiologic studies have shown that C. difficile is often isolated in hospital wards, including the floors, door handles, and furniture, even weeks after patients with it have been removed from the area.
• Because of the sporulating properties of this organism, all these observations have suggested an important role for cross-contamination between patients, contact with environmental surfaces, and transmission via hands of medical personnel.
• During the past few years, there has been renewed interest in C. diff diarrhea reflecting a form of disease that is more frequent, more severe, and more refractory to standard treatment. These observations are explained by the presence of a new strain of C. diff, designated NAP-1, which produces more toxins A and B and is resistant.
Both C. difficile toxins A and B exhibit potent enterotoxic and cytotoxic effects that are responsible for the clinical manifestations. The mechanism of action is by toxin binding on intestinal receptors, leading to disruption of the cellular skeleton and intracellular junctions. Protein synthesis and cell division are inhibited. Important inflammatory mediators attract neutrophils and monocytes, increasing capillary permeability, tissue necrosis, hemorrhage, and edema.
Clinical Presentation and Diagnosis. The clinical manifestations of C. diff may vary from mild diarrhea to fulminant colitis. If a patient develops diarrhea several days to weeks (even up to 8 weeks) after using antibiotics, evaluate for C. diff. Marked leukocytosis and systemic symptoms are evident in severe cases.
Until a few years ago the diagnostic method of choice for C. difficile colitis was the enzyme­linked immunosorbent assay (ELISA), based on toxin detection in the stool. While ELISA is fast, relatively inexpensive, and has excellent specificity, its sensitivity is variable (ranging 75−85%). The newest preferred method of diagnosis is the nucleic acid amplification (LAMP, loop-mediated isothermal amplification) assay, which may include the real-time polymerase chain reaction (PCR) or loop-mediated isothermal amplification test, both of which detect the toxin A and B genes responsible for the production of toxins. They have a sensitivity of 90−100% and a specificity of 94−100%. There is no benefit to testing multiple stool speci­mens or repeat testing following a positive test.
Treatment. Metronidazole is the drug of choice along with discontinuation of antibiotics (if feasible) and supportive therapy. If the diagnosis is highly likely and the patient is seriously ill, metronidazole may be given empirically before the test results. Oral vancomycin is reserved for the following conditions:
• Failed therapy with metronidazole
• Organisms resistant to metronidazole
• Patient is allergic to or cannot tolerate metronidazole
• Patient is pregnant or a child age <10
• Patient is critically ill
If the symptoms resolve but there is a recurrence (~ 30% in some studies), then retreat with metronidazole. Also, IV metronidazole can be used to treat C. difficile colitis if the patient is unable to use oral medications. (This is not true of vancomycin. IV vancomycin will have no effect in the bowel because it does not pass the bowel wall. Similarly, oral vancomycin will have no systemic effect.)
94
A new drug, fidaxomicin, is not more effective than vancomycin or metronidazole for the first episode. Fidaxomicin seems to decrease the number of episodes of recurrent C. difficile colitis.
Chapter 4
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Lactose Intolerance
Pathogenesis. Lactose intolerance is perhaps the single most common potential cause of diar­rhea because of the enormously high prevalence of lactase deficiency. This is a disorder so com­mon that the testing and treatment are generally empiric.
Clinical Presentation. The diarrhea produced is associated with gas and bloating, but never has blood or leukocytes in it. Despite the malabsorption of lactose, weight loss does not occur.
Diagnosis and Treatment. A precise diagnosis can be established by finding an increased stool osmolality and increased osmolar gap. The osmolar gap means that the difference between the osmolality measure in the stool and the osmolality calculated from the sodium and potassium levels is >50 mOsm/kg. In other words, the measured stool osmolality is great­er than would be expected just by the level of sodium and potassium. The extra osmoles are from lactose. Other causes of an increased stool osmolar gap are magnesium and polyethylene glycol in the stool, also nutrient malabsorption pancreatic insufficiency, celiac sprue, and bacterial overgrowth.
The routine way to diagnose lactose intolerance is simply to remove milk, cheese, ice cream, and all other dairy products (except yogurt) from the diet and observe for resolution of symptoms, which should occur within 24 to 36 hours. (This is quite different from celiac dis­ease, in which resolution of diarrheal symptoms make take weeks after stopping the ingestion of gluten-containing foods.)
l Gastroenterology
If resolution of symptoms does occur within 24 to 36 hours, then dietary changes are the best therapy. The patient can use lactase supplements.
Irritable Bowel Syndrome
Pathogenesis. Although it is often described at the same time as diarrheal illnesses, irritable bowel syndrome (IBS) is predominantly a pain syndrome of unknown etiology. IBS is an idio­pathic disorder in which there is increased frequency of the normal peristaltic and segmenta­tion contractions of the bowel. Pain is often relieved by a bowel movement.
Clinical Presentation. Twenty percent of patients with IBS have constipation only. A large number have diarrhea alone or diarrhea alternating with constipation. Everyone has pain.
No nocturnal symptoms. The majority are women with history of childhood abuse.
Diagnosis. There is no specific diagnostic test for IBS. The physician must first exclude lac­tose intolerance, inflammatory bowel disease, celiac disease, carcinoid, Giardia infection, and anatomic defects of the bowel as the cause.
The diagnostic criteria, called Rome criteria, must occur for at least 3 months:
• Pain relieved by a bowel movement or by a change in bowel habit (e.g., when you develop diarrhea, the pain goes away)
• Fewer symptoms at night
• Diarrhea alternating with constipation
No constitutional signs or symptoms, such as fever, weight loss, anorexia, or anemia.
Treatment. There is no clear definitive therapy for IBS. All patients should be placed on a high­fiber diet in an attempt to increase the bulk of the stool. Those with diarrhea-predominant dis­ease should receive antidiarrheal agents, such as loperamide or diphenoxylate.
95
USMLE Step 2 CK
l Internal Medicine
Antispasmodic agents are used on a trial-and-error basis until the most effective agent is found. Examples of antispasmodics are hyoscyamine, dicyclomine, and the belladonna alka­loids. The presumptive mechanism of these agents is that they will relax the bowel wall mus­culature and diminish the pain.
Resistant cases may respond to tricyclic antidepressants. The presumptive mechanism is that the tricyclics are anticholinergic and will relax the bowel. There is also a high frequency of depression in many of these patients, and it is assumed that the tricyclics have an analgesic effect with neuropathic pain.
A newer agent is tegaserod, which is used in constipation-predominant IBS. The major com­plication of therapy with tegaserod is diarrhea. Another newer agent is alosetron. Alosetron is used in diarrhea-predominant IBS, and it slows motility. Both of these agents work by manipu­lating serotonin levels in the bowel.
Carcinoid Syndrome
Pathogenesis. Carcinoid syndrome describes tumors of the neuroendocrine system. They are most often located in the appendix and the ileum. Bronchial carcinoids are rare but are highly symptomatic because the serotonin produced from a bronchial carcinoid does not get detoxified in the liver and is released directly into the circulation. With the exception of bron­chial carcinoid, carcinoid syndrome by definition implies metastatic disease. Until there is an enormous tumor burden, the liver is able to neutralize all of the serotonin released by the car­cinoid in the bowel. This usually does not happen until the metabolic capacity of the liver has been overwhelmed by metastatic disease.
Clinical Presentation. The presentation of carcinoid syndrome is with diarrhea, flushing, tachy­cardia, and hypotension. A rash may develop from niacin deficiency, which is a direct result of the carcinoid. Serotonin and niacin are both produced from tryptophan. If there is an overpro­duction of serotonin, it produces a tryptophan deficiency, which leads to a deficiency of niacin. Endocardial fibrosis also occurs because of a constant exposure of the right side of the heart to the serotonin. This leads to tricuspid insufficiency and pulmonic stenosis.
Diagnosis. The diagnosis is confirmed with a urinary 5-hydroxyindolacetic acid level (5-HIAA).
Treatment. Therapy is generally based on controlling the diarrhea with octreotide, which is a
somatostatin analog. Very few carcinoids are sufficiently localized to be amenable to surgical resection. If a tumor does happen to be localized, then it should be resected. This is most often possible with bronchial carcinoid. Surgery is also used to relieve obstruction of the bowel.
MALABSORPTION SYNDROMES
Pathogenesis. The major causes of fat malabsorption are celiac disease and chronic pancreatitis, although tropical sprue and Whipple disease are extremely rare but possible causes. What they all have in common is the production of diarrhea characterized as greasy, oily, floating, and fatty, with a particularly foul smell, as if fat were fermenting. This type of diarrhea with fat is referred to as steatorrhea.
All malabsorption syndromes are characterized by weight loss because fat has the highest caloric content of all the foods. In addition, there is malabsorption of the fat-soluble vitamins A, D, E, and K. This can lead to hypocalcemia and easy bruising, as well as prolongation of the prothrombin time.
96
Chapter 4
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Iron malabsorption occurs if there is involvement of the duodenum where iron is normally absorbed. Iron deficiency anemia is evident in all patients with celiac sprue. Macrocytic ane­mia results from folate being malabsorbed. Vitamin B12 malabsorption is from damage or loss of the mucosal surface of the terminal ileum.
Clinical Presentation. All of the malabsorption syndromes present with chronic diarrhea. The only unique feature of celiac disease is dermatitis herpetiformis. This is a vesicular skin rash on the extensor surfaces of the body seen in approximately 10% of patients. Even without dermatitis herpetiformis, celiac disease is the most likely etiology of fat malabsorption because it is the most common.
l Gastroenterology
Patients with chronic pancreatitis will give a history of repeated episodes of pancreatitis from alcohol or gallstones. Tropical sprue is suspected when there is a history of being in a tropi­cal country. Whipple disease is by far the rarest. In addition to the usual presentation of a fat malabsorption, Whipple disease is characterized by dementia (10%), arthralgias (80%), and ophthalmoplegia.
Diagnosis. Celiac disease is first diagnosed by testing for the presence of antiendomysial and antitransglutaminase antigliadin antibodies. The most accurate test is a small bowel biopsy, which shows flattening of villi. Even if the antibody tests confirm the diagnosis of celiac disease, the bowel biopsy should be done anyway to exclude small bowel lymphoma. And because there is very little that is unique about tropical sprue, it is yet another reason to always do a small bowel biopsy.
Just removing gluten (wheat, rye, and oats) from the diet is not a very accurate way of estab­lishing the diagnosis because the circulating antibodies will continue to be present for weeks after stopping the ingestion of gluten.
Chronic pancreatitis is diagnosed from the history of repeated episodes of pancreatitis and is confirmed by finding calcification of the pancreas on x-ray and CT scan. The most accurate test, although rarely done, is a secretin test, or finding a low trypsin level. Secretin normally causes a voluminous release of bicarbonate and other pancreatic enzymes into the duodenum. If you place a nasogastric tube into the duodenum and inject secretin into the blood, the pan­creas will not release bicarbonate or enzymes into the duodenum in a patient with chronic pancreatitis.
d-xylose testing was performed in the past to help distinguish between celiac disease and chron-
ic pancreatitis. d-xylose is a monosaccharide that requires no digestion to be absorbed. If there is no absorption of d-xylose, it means there is a bowel-wall abnormality. d-xylose was absorbed and excreted in chronic pancreatitis, but not in celiac disease, Whipple disease, or tropical sprue, in which there is a bowel-wall abnormality. Antibody testing has largely replaced
d-xylose test-
ing. In addition, the presence of the deficiency of iron, folate, and carotene also point to a muco­sal defect because they do not need pancreatic enzymes to be absorbed. Vitamin B12 is malab­sorbed in pancreatic insufficiency and celiac disease. Pancreatic enzymes are necessary to absorb B12. Vitamin K and calcium are malabsorbed because of fat malabsorption.
Clinical Pearl
Antibodies Seen in Celiac Disease
• IgA endomysial antibody
• IgA tissue transglutaminase antibody
• IgG tissue transglutaminase antibody
• IgA deamidated gliadin peptide
• IgG deamidated gliadin peptide
Anti-tissue transglutaminase antibody (IgA) is the most sensitive and specific. In patients with IgA deficiency, IgA endomysial and transglutaminase antibodies are falsely normal.
Tropical sprue and Whipple’s disease are diagnosed by finding organisms on a bowel-wall biopsy. The single most sensitive test for Whipple’s disease is a polymerase chain reaction (PCR) of the bowel biopsy. A positive Tropheryma whippelii biopsy shows foamy macrophages that are PAS positive.
97
USMLE Step 2 CK
l Internal Medicine
Treatment. Celiac disease is managed by adhering to a gluten-free diet (no wheat, oats, rye, or barley). Dapsone is used when celiac patients have dermatitis herpetiformis. Chronic pancre­atitis can be managed by orally replacing all the deficient enzymes. Amylase, lipase, and trypsin can all be taken in a single combination pill. Tropical sprue is treated with trimethoprim/sulfa­methoxazole or doxycycline for 6 months. Whipple’s disease is also treated with trimethoprim/ sulfamethoxazole or doxycycline, but it can also be treated with ceftriaxone for 1 year.
Although all malabsorption syndromes are associated with multiple deficiencies, note some complications:
• Celiac disease is associated with GI lymphoma and adenocarcinoma; patients are at risk for adenocarcinoma of the intestine.
• Celiac sprue is associated with lymphoma (enteropathy-associated T cell lymphoma) (10-15% of cases); it is unclear whether therapy with gluten-free diet decreases inci­dence of lymphoma.
DIVERTICULAR DISEASE
Diverticulosis
Diverticulosis is so common in older populations in the Western world as to almost be con­sidered simply a normal part of aging rather than a disease. Diverticulosis is presumably caused by a lack of fiber in the diet to give bulk to stool. There is a subsequent rise in intraco­lonic pressure, leading to outpocketing of the colon. It is prevalent in 50% of persons age >50, with even higher rates in older populations.
Clinical Presentation. Most of the time, these patients are asymptomatic. When they have symptoms, it is of left lower quadrant abdominal pain that can be colicky in nature.
Diagnosis. Diverticulosis is diagnosed with colonoscopy. Endoscopy is superior to barium studies, particularly when bleeding is present. Diverticula are more common on the left in the sigmoid, but bleeding occurs more often from diverticula on the right because of thinner mucosa and more fragile blood vessels. When bleeding occurs from diverticula, it is painless.
Treatment. Diverticulosis by itself is managed only with increasing fiber in the diet with prod­ucts like Metamucil, dietary fiber in bran, or bulking agents, such as psyllium husks.
Diverticulitis
Diverticulitis is from an infection occurring in one of the diverticula. This occurs more fre­quently when there is a blockage of the diverticular entrance in the colon from nuts or corn.
Clinical Presentation. Diverticulitis is distinguished from uninfected diverticula by the pres­ence of fever, tenderness, more intense pain, and an elevation of the white blood cell count in the blood.
Diagnosis. Diverticulitis is confirmed by CT scanning. Barium studies and endoscopy are relatively contraindicated in diverticulitis because there is a slightly higher risk of causing perforation. There is no risk of perforation with CT scan.
98
Chapter 4
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Treatment. Diverticulitis is treated with antibiotics such as ciprofloxacin and metronidazole. The other choices are ampicillin/sulbactam, piperacillin/tazobactam, or the combination of cefotetan or cefoxitin with gentamicin. Mild disease can be treated with oral antibiotics, such as amoxicillin/clavulanic acid (Augmentin).
CONSTIPATION
A 72-year-old woman has a history of upper GI tract bleeding and iron-deficiency anemia, for which she has recently been started on oral ferrous sulfate iron replacement. She also has a history of diabetes with peripheral neuropathy, for which she is on amitriptyline. She has untreated hypothyroidism, but is treated for hypertension with nifedipine. Currently, she has constipation, and when the stool does pass, it is very dark in color, almost black.
Pathogenesis. The most common cause of constipation is generally a lack of dietary fiber and insufficient fluid intake. Calcium-channel blockers, oral ferrous sulfate, hypothyroidism, opi­ate analgesics, and medications with anticholinergic effects, such as the tricyclic antidepres­sants, all cause constipation. In the case of the patient described above, the most likely cause of the constipation is the ferrous sulfate.
l Gastroenterology
Clinical Presentation. As written in the case, this patient’s stool is dark. This only occurs with bleeding, bismuth subsalicylate ingestion, and iron replacement. However, GI bleeding gives diarrhea and not constipation because blood acts as a cathartic. Blood causes diarrhea, and iron tablets cause constipation.
Treatment. The general management is to stop medications that cause constipation, and then to make sure the patient consumes 20–30 grams of fiber daily and is well hydrated. Bulking agents, such as those used to manage diverticular diseases, are also helpful. Drug treat­ment of constipation includes milk of magnesia, cascara, bisacodyl, and docusate (Colace). Enemas can be used for acute and serious constipation. Lactulose and polyethylene glycol (GoLYTELY) can also be very effective.
COLON CANCER
Pathogenesis. The lifetime risk of colon cancer is >6%. Most cases occur sporadically, which is to say there is no clearly identified etiology. Diets that are high in red meat and fat lead to an increased risk for colon cancer, and smoking also increases the risk for colon cancer.
Clinical Presentation. Patients present with heme-positive, brown stool and chronic anemia when the cancer is in the right side of the colon. Left-sided lesions and cancer of the sigmoid colon are more often associated with symptoms of obstruction and with narrowing of stool caliber. This is because the right side of the colon is wider, and the stool is more liquid in that part of the bowel, making obstruction less likely on the right. Endocarditis by Streptococcus bovis and Clostridium septicum is often associated with colon cancer. Any patient presenting with endocarditis due to one of these organisms requires a GI work-up.
99